Abstract
Sipuleucel-T* [Provenge] prolongs prostate-specific antigen (PSA) doubling time in patients with androgen-dependent prostate cancer,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.2165/00128413-200615640-00017
Journal: Inpharma Weekly | Publication Date: Nov 1, 2006 |
Sipuleucel-T* [Provenge] prolongs prostate-specific antigen (PSA) doubling time in patients with androgen-dependent prostate cancer,
Join us for a 30 min session where you can share your feedback and ask us any queries you have